Obese patients with schizophrenia and schizoaffective disorder: Efficacy of injectable long-acting risperidone

被引：0
|
作者：
Permuy, RT
Turner, MS
Bouhours, P
机构：
[1] Zwolse Poort, Raalte, Netherlands
[2] Larkfield Ctr, Glasgow, Lanark, Scotland
[3] Janssen Cilag, Issy Les Moulineaux, France
来源：
SCHIZOPHRENIA RESEARCH | 2004年 / 67卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
下载
收藏
页码：175 / 175
页数：1
相关论文
共 50 条
  • [31] Long-acting injectable risperidone
    Ehret, MJ
    Fuller, MA
    ANNALS OF PHARMACOTHERAPY, 2004, 38 (12) : 2122 - 2127
  • [32] Subjective attitude to risperidone long-acting injectable (RLAI): Results from a long-term Italian study in subjects with schizophrenia or schizoaffective disorder
    Rossi, A.
    Bernareggi, M. M.
    Giustra, M. G.
    EUROPEAN PSYCHIATRY, 2008, 23 : S167 - S167
  • [33] EFFICACY AND TOLERABILITY AMONG PATIENTS WITH RECENT ONSET SCHIZOPHRENIA TREATED WITH RISPERIDONE LONG-ACTING INJECTABLE (RLAI)
    Napryeyenko, Oleksandr
    Burba, Benjaminas
    Martinez, Guadalupe
    Neznanov, Nikolay
    Fischel, Tsvi
    Bayle, Franck
    Corrivetti, Giulio
    Smeraldi, Enrico
    Rabinowitz, Jonathan
    SCHIZOPHRENIA RESEARCH, 2010, 117 (2-3) : 496 - 496
  • [34] Management of schizophrenia - Defining the role of long-acting injectable risperidone
    Curran, Monique P.
    Keating, Gillian M.
    DISEASE MANAGEMENT & HEALTH OUTCOMES, 2006, 14 (02) : 107 - 125
  • [35] Duration of Pharmacotherapy with Long-Acting Injectable Risperidone in the Treatment of Schizophrenia
    Mohamed, Somaia
    Rosenheck, Robert
    Harpaz-Rotem, Ilan
    Leslie, Douglas
    Sernyak, Michael J.
    PSYCHIATRIC QUARTERLY, 2009, 80 (04) : 241 - 249
  • [36] Impact of risperidone long-acting injectable on hospitalization and medication use in patients with schizophrenia
    Beauclair, L.
    Lam, A.
    McCormick, J.
    Luong, D.
    Camacho, F.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S263 - S263
  • [37] Duration of Pharmacotherapy with Long-Acting Injectable Risperidone in the Treatment of Schizophrenia
    Somaia Mohamed
    Robert Rosenheck
    Ilan Harpaz-Rotem
    Douglas Leslie
    Michael J. Sernyak
    Psychiatric Quarterly, 2009, 80 : 241 - 249
  • [38] Impact of risperidone long-acting injectable on hospitalization and medication use in patients with schizophrenia
    Beauclair, L
    Lam, A
    McCormick, J
    Luong, D
    Camacho, F
    VALUE IN HEALTH, 2005, 8 (06) : A202 - A203
  • [39] Long-acting injectable risperidone: Efficacy and safety of the first long-acting atypical antipsychotic
    Kane, JM
    Eerdekens, M
    Lindenmayer, JP
    Keith, SJ
    Lesem, M
    Karcher, K
    AMERICAN JOURNAL OF PSYCHIATRY, 2003, 160 (06): : 1125 - 1132
  • [40] Cognitive improvements in patients with schizophrenia with risperidone long-acting injectable: Relationship to functioning?
    Pandina, G
    Bilder, R
    Harvey, P
    Lasser, RA
    Rodriguez, S
    Turkoz, I
    Gharabawi, G
    SCHIZOPHRENIA BULLETIN, 2005, 31 (02) : 500 - 500
12345